Delisting riskPopularity #4,543
MDxHealth (MDXH)
Molecular prostate-cancer tests for testing and treatment decisions.
$0.6000
vs last close+0.00 (+0.02%)
Something off on this page? Send us feedback.
EPSReportedEstimate
Aug '24Nov '24Feb '25May '25Aug '25Nov '25May '26Aug '26
Reported−$0.31−$0.40−$0.14−$0.19−$0.15−$0.16−$0.19−$0.18
Estimate−$0.26−$0.27−$0.21−$0.13−$0.13−$0.12−$0.13−$0.19
Surprise−19.2%−48.1%+33.3%−46.2%−15.4%−33.3%−46.2%+6.9%
RevenueReportedEstimate
Aug '24Nov '24Feb '25May '25Aug '25Nov '25May '26Aug '26
Reported$42.0M$23.3M$24.7M$24.3M$26.6M$27.4M$23.9M$27.2M
Estimate$21.2M$21.5M$22.7M$23.9M$26.3M$26.3M$30.9M$26.1M
Surprise+97.7%+8.4%+9.1%+1.7%+1.1%+4.3%−22.6%+4.1%
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$0.01 | — | — |
| Jun 2028 | −$0.01 | — | — |
| Dec 2027 | −$0.05 | — | — |
| Sep 2027 | −$0.03 | — | — |
| Jun 2027 | −$0.06 | — | — |
| Mar 2027 | −$0.10 | — | — |
| Dec 2026 | −$0.09 | — | — |
| Sep 2026 | −$0.09 | — | — |
| Aug 2026 | −$0.19 | −$0.18 | +6.9% |
| May 2026 | −$0.13 | −$0.19 | −46.2% |
| Nov 2025 | −$0.12 | −$0.16 | −33.3% |
| Aug 2025 | −$0.13 | −$0.15 | −15.4% |
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Oct 2022 | |||
| Aug 2022 | |||
| Apr 2022 | |||
| Mar 2022 | |||
| Aug 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Jun 2020 | |||
| Dec 2019 | |||
| Jun 2019 | |||
| Dec 2018 | |||
| Jun 2018 | |||
| Dec 2017 | |||
| Jun 2017 | |||
| Dec 2016 | |||
| Jun 2016 | |||
| Dec 2015 | |||
| Jun 2015 | |||
| Dec 2014 | |||
| Jun 2014 | |||
| Dec 2013 | |||
| Jun 2013 | |||
| Dec 2012 | |||
| Jun 2012 | |||
| Dec 2011 | |||
| Jun 2011 | |||
| Dec 2010 | |||
| Jun 2010 | |||
| Dec 2009 | |||
| Jun 2009 | |||
| Dec 2008 | |||
| Jun 2008 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$0.01 | — | — | $39.2M | — | — | — |
| Jun 2028 | −$0.01 | — | — | $37.6M | — | — | — |
| Dec 2027 | −$0.05 | — | — | $33.5M | — | — | — |
| Sep 2027 | −$0.03 | — | — | $42.2M | — | — | — |
| Jun 2027 | −$0.06 | — | — | $31.2M | — | — | — |
| Mar 2027 | −$0.10 | — | — | $36.2M | — | — | — |
| Dec 2026 | −$0.09 | — | — | $28.3M | — | — | — |
| Sep 2026 | −$0.09 | — | — | $35.8M | — | — | — |
| Aug 13, 2026 | −$0.19 | −$0.18 | +6.9% | $26.1M | $27.2M | +4.1% | +74.9% |
| May 13, 2026 | −$0.13 | −$0.19 | −46.2% | $30.9M | $23.9M | −22.6% | −49.5% |
| Nov 12, 2025 | −$0.12 | −$0.16 | −33.3% | $26.3M | $27.4M | +4.3% | −3.6% |
| Aug 5, 2025 | −$0.13 | −$0.15 | −15.4% | $26.3M | $26.6M | +1.1% | +10.4% |
| May 14, 2025 | |||||||
| Feb 26, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Aug 21, 2024 | |||||||
| May 1, 2024 | |||||||
| Mar 6, 2024 | |||||||
| Nov 8, 2023 | |||||||
| Aug 23, 2023 | |||||||
| May 15, 2023 | |||||||
| Mar 8, 2023 | |||||||
| Oct 27, 2022 | |||||||
| Aug 25, 2022 | |||||||
| Apr 27, 2022 | |||||||
| Mar 2, 2022 | |||||||
| Aug 26, 2021 | |||||||
| Mar 3, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Jun 30, 2016 | |||||||
| Dec 31, 2015 | |||||||
| Jun 30, 2015 | |||||||
| Dec 31, 2014 | |||||||
| Jun 30, 2014 | |||||||
| Dec 31, 2013 | |||||||
| Jun 30, 2013 | |||||||
| Dec 31, 2012 | |||||||
| Jun 30, 2012 | |||||||
| Dec 31, 2011 | |||||||
| Jun 30, 2011 | |||||||
| Dec 31, 2010 | |||||||
| Jun 30, 2010 | |||||||
| Dec 31, 2009 | |||||||
| Jun 30, 2009 | |||||||
| Dec 31, 2008 | |||||||
| Jun 30, 2008 |